PCM
CCRN

Prelude Capital Management’s Cross Country Healthcare CCRN Stock Holding History

Prelude Capital Management’s Portfolio CCRN Stock Details CCRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$479K Sell
50,948
-12,784
-20% -$114K 0.04% 532
2025
Q4 		$516K Sell
63,732
-50,024
-44% -$547K 0.04% 517
2025
Q3 		$1.62M Buy
113,756
+22,252
+24% +$294K 0.13% 209
2025
Q2 		$1.19M Sell
91,504
-57,871
-39% -$795K 0.12% 221
2025
Q1 		$2.22M Sell
149,375
-49,185
-25% -$845K 0.17% 139
2024
Q4 		$3.61M Buy
+198,560
New +$2.67M 0.23% 90
2022
Q2 		– Sell
-24,898
Closed -$540K – 1823
2022
Q1 		$540K Buy
+24,898
New +$540K 0.02% 826
2020
Q4 		– Sell
-2,818
Closed -$18K – 1359
2020
Q3 		$18K Buy
2,818
+900
+47% +$5.7K ﹤0.01% 1344
2020
Q2 		$12K Hold
1,918
– – ﹤0.01% 1526
2020
Q1 		$13K Buy
1,918
+628
+49% +$5.95K ﹤0.01% 1074
2019
Q4 		$15K Sell
1,290
-1,910
-60% -$21.6K ﹤0.01% 1640
2019
Q3 		$33K Buy
+3,200
New +$31.5K ﹤0.01% 1287
2018
Q3 		– Sell
-3,246
Closed -$37K – 1747
2018
Q2 		$37K Buy
+3,246
New +$38.7K ﹤0.01% 1199
2017
Q4 		– Sell
-9,488
Closed -$135K – 1386
2017
Q3 		$135K Buy
9,488
+1,207
+15% +$15.1K 0.01% 778
2017
Q2 		$107K Sell
8,281
-10,254
-55% -$132K 0.01% 757
2017
Q1 		$266K Sell
18,535
-16,444
-47% -$242K 0.03% 465
2016
Q4 		$546K Buy
34,979
+9,596
+38% +$131K 0.07% 304
2016
Q3 		$299K Buy
25,383
+22,027
+656% +$290K 0.03% 433
2016
Q2 		$47K Sell
3,356
-13,310
-80% -$176K 0.01% 1029
2016
Q1 		$194K Buy
16,666
+1,966
+13% +$25K 0.03% 567
2015
Q4 		$241K Buy
14,700
+13,700
+1,370% +$218K 0.04% 474
2015
Q3 		$14K Buy
+1,000
New +$13.6K ﹤0.01% 1293
2015
Q1 		– Sell
-1,962
Closed -$24K – 1953
2014
Q4 		$24K Buy
+1,962
New +$20K ﹤0.01% 1676
2014
Q1 		– Sell
-8,594
Closed -$86K – 1884
2013
Q4 		$86K Buy
+8,594
New +$59.6K 0.01% 912

Other funds holding CCRN

Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return

Prelude Capital Management's CCRN Position: Q1 2026 in Review

Prelude Capital Management reduced its Cross Country Healthcare (CCRN) stake by 20% in Q1 2026, selling an estimated $114K and leaving 50,948 shares worth $479K. The position accounts for 0.04% of the portfolio, ranked #532.

Prelude Capital Management first reported a position in CCRN in Q4 2013 and has held it in 24 quarters since. The position peaked at $3.61M in Q4 2024. 151 funds tracked by Wall St. Rank hold CCRN as of Q1 2026.

  • Prelude Capital Management held 50,948 shares of Cross Country Healthcare worth $479K as of Q1 2026.
  • Prelude Capital Management sold 12,784 Cross Country Healthcare shares in Q1 2026, an estimated $114K.
  • Cross Country Healthcare made up 0.04% of Prelude Capital Management's portfolio in Q1 2026, its #532 holding.
  • Prelude Capital Management first reported a position in Cross Country Healthcare in Q4 2013 and has held it in 24 quarters since.
  • Prelude Capital Management's Cross Country Healthcare position peaked at $3.61M in Q4 2024.
  • 151 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.